A popular and respected scientist is reported to be in line to lead the nation's most important cancer research office.| STAT
The 48th annual scientific symposium featured lively talks on cancer discovery and application, marked the kickoff of UNC Lineberger’s 50th anniversary as an NCI-designated cancer center, and celebrated Shelley Earp, MD, for his leadership at UNC and nationally. The post Scientific symposium celebrates UNC Lineberger’s 50th anniversary appeared first on UNC Lineberger.| UNC Lineberger
The post Precision Medicine Online: Iovance’s Amtagvi Shows Modest Monotherapy Activity in Head and Neck Cancer appeared first on UNC Lineberger.| UNC Lineberger
A phase 2 study reveals autologous TIL therapy's potential to stabilize recurrent head and neck cancer, offering hope for improved treatment options.| www.targetedonc.com
Robert L. Ferris, MD, PhD, editor-in-chief of Targeted Therapies in Oncology, discusses his monthly column in this episode of Chief Insights in Oncology.| Targeted Oncology